The effect of injectable scopolamine in patients with major depressive disorders
Phase 3
Recruiting
- Conditions
- Major depressive disorder.Major depressive disorder, single episode
- Registration Number
- IRCT20231017059749N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
Patients with major depressive disorder
Age 18-55 years
Minimum severity of depression based on Hamilton Depression Scale should be higher or equal to 20.
Exclusion Criteria
The existence of psychotic disorder, delirium and bipolar disorderPregnancy or breastfeeding
Taking psychedelic drugs, antidepressants in the last month
ECT in the last two months
History of cardiovascular disease
Hypothyroidism
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hamilton depression scale. Timepoint: The beginning of the study, the fourth day, the seventh day, the fourteenth day, the twenty-eighth day. Method of measurement: Hamilton questionnaire.
- Secondary Outcome Measures
Name Time Method